(37 days)
Not Found
No
The summary describes a standard ultrasound system with software for image display and processing, but there is no mention of AI or ML capabilities for image analysis, interpretation, or other functions.
No
The device is described as an "ultrasound imaging system" intended for "diagnostic imaging" and "fluid flow analysis," which are diagnostic rather than therapeutic functions.
Yes
The "Intended Use / Indications for Use" section explicitly states that the Clarius Ultrasound Scanner is "intended for diagnostic imaging" and "indicated for diagnostic ultrasound imaging." The "Device Description" also refers to it as a "diagnostic ultrasound system."
No
The device description explicitly states that the system comprises wireless transducers, battery packs, and chargers, which are hardware components essential for acquiring the ultrasound data. While it uses software on a COTS device for display, it is not solely software.
Based on the provided information, the Clarius Ultrasound Scanner is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body, such as blood, urine, or tissue, to provide information for diagnosis, monitoring, or screening.
- Clarius Ultrasound Scanner Function: The Clarius Ultrasound Scanner uses sound waves to create images of internal structures within the body. It is a non-invasive imaging system that operates in vivo (within the living body), not in vitro (in glass or outside the body).
- Intended Use: The intended use clearly states it is for "diagnostic imaging" and "fluid flow analysis" by applying the transducer to the body.
- Device Description: The description details how the device transmits and receives sound waves to create images of anatomical structures.
Therefore, the Clarius Ultrasound Scanner falls under the category of medical imaging devices, not In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
The Clarius Ultrasound Scanner is a software-based ultrasound imaging system and accessories, intended for diagnostic imaging in B-mode, M-mode, Color Doppler, Power Doppler, and Combined (B+M; B+CD; and B+PD). It is indicated for diagnostic ultrasound imaging and fluid flow analysis in the following applications: ophthalmic, fetal, abdominal, intra-operative (non-neurological), pediatric, small organ, cephalic (adult), musculo-sketal (conventional, superficial), urology, cardiac (adult, pediatric), fetal echo, peripheral vessel, carotid, and procedural guidance of needles into the body.
The system is a transportable ultrasound system intended for use in environments where is provided by trained healthcare professionals.
Prescription Use (Part 21 CFR 801 Subpart D)
Product codes (comma separated list FDA assigned to the subject device)
IYN, IYO, ITX
Device Description
The Clarius Ultrasound System is a portable, general-purpose, software-controlled, diagnostic ultrasound system used to acquire and display high-resolution, real-time ultrasound data through a commercial off the-shelf (COTS) iOS or Android device. The Clarius Ultrasound System comprises a series of wireless transducers employing Bluetooth and Wi-Fi-based technology to communicate with traditional tablet/smartphone devices via direct Wi-Fi. This allows the user to export ultrasound images and display them across a range of portable personal devices.
The Ultrasound Probe contains piezoelectric material that transmits high frequency, non-ionizing sound waves to the designated region of the body and converts the subsequent echoes detected to electronic signals in order to construct an image of the internal structures of an anatomical field. This image is sent wirelessly to an external (COTS) iOS or Android viewing device on which the image can be displayed. The transducer houses a battery and power generator, multichannel beam former, pre-scan converter, and Wi-Fi components. The battery is removable and comes with a separate charger. Communication between the transducer and the compatible viewing device will be via Wi-Fi Direct® (Ad-Hoc mode with security) for easy pairing.
The Clarius Ultrasound System product/package components include:
- Software:
- The Ultrasound App (Clarius App) for iOS; OR
- The Ultrasound App (Clarius App) for Android.
- Transducers/Scanners:
- Clarius C3 Scanner (C3 Convex Transducer);
- Clarius C3 Scanner (C3 Convex Transducer) with Clarius C3-L Clip-on;
- Clarius C7 Scanner (C7 Convex Transducer); OR
- Clarius L7 Scanner (L7 Linear Transducer).
- Accessories:
a. Clarius-Built:
- Battery Pack (Li-ion); and
- Battery Charger.
b. OEM/Off-The-Shelf Product(s):
- Medical Power Supply (Off-the-shelf power adaptor from SL Power Electronics, USA; Model Number ME20A1203B02; Approved in the US); and
- Aquasonic 100 Ultrasound Transmission Gel (Off-the-shelf ultrasound gel from Parker Laboratories Inc., USA; Approved in the US).
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
Ophthalmic, fetal, abdominal, intra-operative (non-neurological), pediatric, small organ (Thyroid, Prostate, Scrotum, Breast), cephalic (adult), musculo-skeletal (conventional, superficial), urology, gynecology, cardiac (adult, pediatric), fetal echo, peripheral vessel, carotid.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Trained healthcare professionals in professional healthcare facilities, Emergency Medical Service, ambulance, or rotary aircraft environments.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Nonclinical performance tests show compliance to the following standards: AAMI/ANSI ES60601-1, IEC 60601-1-2, IEC 60601-1-6, IEC 60601-1-12, IEC 60601-2-37, IEC 62133, IEC 62366, ISO 10993-1, ISO 10993-5, ISO 10993-10, ISO-10993-12, ISO 62304, ISO 15223-1, ISO 14971, NEMA UD 2.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
Public Health Service
Image /page/0/Picture/2 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. Inside the circle is a stylized symbol consisting of three abstract human profiles facing to the right, with flowing lines suggesting movement or connection.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
September 14, 2017
Clarius Mobile Health Corp. % Mr. Mark Job Official Correspondent Regulatory Technology Services. LLC 1394 25th Street, NW BUFFALO MN 55313
Re: K172385
Trade/Device Name: Clarius Ultrasound Scanner Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN, IYO, ITX Dated: August 4, 2017 Received: August 8, 2017
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR
1
Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely.
Michael D. O'Hara
Robert Ochs. Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known)
Device Name Clarius Ultrasound Scanner
Indications for Use (Describe)
The Clarius Ultrasound Scanner is a software-based ultrasound imaging system and accessories, intended for diagnostic imaging in B-mode, M-mode, Color Doppler, Power Doppler, and Combined (B+M; B+Color Doppler; and B+Power Doppler). It is indicated for diagnostic ultrasing and fluid flow analysis in the following applications: ophthalmic, fetal, abdominal, intra-operative (non-neurological), pediatric, small organ, cephalic (adult), musculo-sketal (conventional, superficial), urology, cardiac (adult, pediatric), fetal echo, peripheral vessel, carotid, and procedural guidance of needles into the body.
The system is a transportable ultrasound system intended for use in environments where is provided by trained healthcare professionals.
Type of Use (Select one or both, as applicable) | ||
---|---|---|
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Clinical Application | Mode of Operation | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track 1 Only) | Specific | |||||||
(Tracks 1 & 3) | B | M | Color | |||||
Doppler | Power | |||||||
Doppler | Combined | |||||||
(Specify) | Other* | |||||||
Ophthalmic | Ophthalmic | N | ||||||
Fetal Imaging & Other | Fetal | P | N | N | N | B+M; B+CD; B+PD | ||
Abdominal | P | N | N | N | B+M; B+CD; B+PD | Note 1 | ||
Intra-operative (Abdominal | ||||||||
organs & vascular) | N | N | N | N | B+M; B+CD; B+PD | Note 1 | ||
Laparoscopic | ||||||||
Pediatric | P | N | N | N | B+M; B+CD; B+PD | Note 1 | ||
Small Organ (Thyroid, Prostate, | ||||||||
Scrotum, Breast) | P | N | N | B+CD; B+PD | Note 1 | |||
Neonatal Cephalic | ||||||||
Adult Cephalic | N | N | N | N | B+M; B+CD; B+PD | |||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esophageal (non-Cardiac) | ||||||||
Musculo-skeletal (Conventional) | P | N | N | B+CD; B+PD | Note 1 | |||
Musculo-skeletal (Superficial) | P | N | N | B+CD; B+PD | Note 1 | |||
Intravascular | ||||||||
Other (Urology, Gynecology) | P | N | N | N | B+M; B+CD; B+PD | |||
Cardiac | Cardiac Adult | N | N | N | B+M; B+CD | |||
Cardiac Pediatric | N | N | N | B+M; B+CD | ||||
Intravascular (Cardiac) | ||||||||
Trans-esophageal (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Fetal Echo) | P | N | N | N | B+M; B+CD; B+PD | |||
Peripheral Vessel | Peripheral Vessel | P | N | N | N | B+M; B+CD; B+PD | Note 1 | |
Other (Carotid) | P | N | N | N | B+M; B+CD; B+PD | Note 1 |
System: Clarius Ultrasound Scanner Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
4
System: Clarius Ultrasound Scanner
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
N = new indication; P = previously cleared by FDA; E = added under this appendix
Note 1: Needle Enhancement in B-Mode.
5
Clinical Application | Mode of Operation | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track 1 Only) | Specific | |||||||
(Tracks 1 & 3) | B | M | Color | |||||
Doppler | Power | |||||||
Doppler | Combined | |||||||
(Specify) | Other | |||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging & Other | Fetal | P | N | N | N | B+M; B+CD; B+PD | ||
Abdominal | P | N | N | N | B+M; B+CD; B+PD | |||
Intra-operative (Abdominal | ||||||||
organs & vascular) | N | N | N | N | B+M; B+CD; B+PD | |||
Laparoscopic | ||||||||
Pediatric | P | N | N | N | B+M; B+CD; B+PD | |||
Small Organ (Thyroid, Prostate, | ||||||||
Scrotum, Breast) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | N | N | N | N | B+M; B+CD; B+PD | |||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esophageal (non-Cardiac) | ||||||||
Musculo-skeletal (Conventional) | P | N | N | N | B+M; B+CD; B+PD | |||
Musculo-skeletal (Superficial) | ||||||||
Intravascular | ||||||||
Other (Urology, Gynecology) | P | N | N | N | B+M; B+CD; B+PD | |||
Cardiac | Cardiac Adult | N | N | N | B+M; B+CD | |||
Cardiac Pediatric | N | N | N | B+M; B+CD | ||||
Intravascular (Cardiac) | ||||||||
Trans-esophageal (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Fetal Echo) | P | N | N | N | B+M; B+CD; B+PD | |||
Peripheral Vessel | Peripheral Vessel | P | N | N | N | B+M; B+CD; B+PD | ||
Other (Carotid) | ||||||||
Clinical Application | Mode of Operation | Other* | ||||||
General | ||||||||
(Track 1 Only) | Specific | |||||||
(Tracks 1 & 3) | B | M | Color | |||||
Doppler | Power | |||||||
Doppler | Combined | |||||||
(Specify) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging & Other | Fetal | N | N | N | N | B+M; B+CD; B+PD | ||
Abdominal | N | N | N | N | B+M; B+CD; B+PD | |||
Intra-operative (Abdominal | ||||||||
organs & vascular) | N | N | N | N | B+M; B+CD; B+PD | |||
Laparoscopic | ||||||||
Pediatric | N | N | N | N | B+M; B+CD; B+PD | |||
Small Organ (Thyroid, Prostate, | ||||||||
Scrotum, Breast) | N | N | N | N | B+M; B+CD; B+PD | |||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esophageal (non-Cardiac) | ||||||||
Musculo-skeletal (Conventional) | N | N | N | N | B+M; B+CD; B+PD | |||
Musculo-skeletal (Superficial) | ||||||||
Intravascular | ||||||||
Other (Urology, Gynecology) | N | N | N | N | B+M; B+CD; B+PD | |||
Cardiac | Cardiac Adult | N | N | N | N | B+M; B+CD; B+PD | ||
Cardiac Pediatric | N | N | N | B+M; B+CD | ||||
Intravascular (Cardiac) | ||||||||
Trans-esophageal (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Fetal Echo) | N | N | N | N | B+M; B+CD; B+PD | |||
Peripheral Vessel | Peripheral Vessel | N | N | N | N | B+M; B+CD; B+PD | ||
Other (Carotid) | ||||||||
N = new indication; P = previously cleared by FDA; E = added under this appendix | ||||||||
Note 1: Needle Enhancement in B-Mode. | ||||||||
Clinical Application | Mode of Operation | |||||||
General | ||||||||
(Track 1 Only) | Specific | |||||||
(Tracks 1 & 3) | B | M | Color | |||||
Doppler | Power | |||||||
Doppler | Combined | |||||||
(Specify) | Other* | |||||||
Ophthalmic | N | |||||||
Fetal Imaging & Other | Fetal | |||||||
Abdominal | P | N | N | N | B+M; B+CD; B+PD | Note 1 | ||
Intra-operative (Abdominal | ||||||||
organs & vascular) | N | N | N | N | B+M; B+CD; B+PD | Note 1 | ||
Laparoscopic | ||||||||
Pediatric | P | N | N | N | B+M; B+CD; B+PD | Note 1 | ||
Small Organ (Thyroid, Prostate, | ||||||||
Scrotum, Breast) | P | N | N | B+CD; B+PD | Note 1 | |||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esophageal (non-Cardiac) | ||||||||
Musculo-skeletal (Conventional) | P | N | N | N | B+M; B+CD; B+PD | Note 1 | ||
Musculo-skeletal (Superficial) | P | N | N | N | B+M; B+CD; B+PD | Note 1 | ||
Intravascular | ||||||||
Other (Urology, Gynecology) | ||||||||
Cardiac | Cardiac Adult | |||||||
Cardiac Pediatric | ||||||||
Intravascular (Cardiac) | ||||||||
Trans-esophageal (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Fetal Echo) | ||||||||
Peripheral Vessel | Peripheral Vessel | P | N | N | N | B+M; B+CD; B+PD | Note 1 | |
Other (Carotid) | P | N | N | N | B+M; B+CD; B+PD | Note 1 | ||
N = new indication; P = previously cleared by FDA; E = added under this appendix | ||||||||
Clinical Application | Mode of Operation | |||||||
General | ||||||||
(Track 1 Only) | Specific | |||||||
(Tracks 1 & 3) | B | M | Color | |||||
Doppler | Power | |||||||
Doppler | Combined | |||||||
(Specify) | Other* | |||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging & Other | Fetal | |||||||
Abdominal | ||||||||
Intra-operative (Abdominal | ||||||||
organs & vascular) | ||||||||
Laparoscopic | ||||||||
Pediatric | ||||||||
Small Organ (Thyroid, Prostate, | ||||||||
Scrotum, Breast) | N | |||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esophageal (non-Cardiac) | ||||||||
Musculo-skeletal (Conventional) | N | |||||||
Musculo-skeletal (Superficial) | N | |||||||
Intravascular | ||||||||
Other (Urology, Gynecology) | ||||||||
Cardiac | Cardiac Adult | |||||||
Cardiac Pediatric | ||||||||
Intravascular (Cardiac) | ||||||||
Trans-esophageal (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Fetal Echo) | ||||||||
Peripheral Vessel | Peripheral Vessel | N | ||||||
Other (Carotid) | N |
DEVICE NAME: C3 CONVEX SCANNER Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
6
Device Name: C7 Convex Scanner Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
7
DEVICE NAME: L7 LINEAR SCANNER Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
8
Device Name: C3 Convex Scanner with C3-L Clip-on Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
9
Image /page/9/Picture/0 description: The image shows the Clarius logo. The logo consists of an orange symbol that looks like three concentric letter C's, followed by the word "clarius" in dark blue, sans-serif font. The logo is simple and modern, with a focus on the company name.
510(k) Summary
1. Submitter's name, address, telephone number, and contact person:
Submitter: | Abhijit Ahir |
---|---|
Director of QA/RA | |
Clarius Mobile Health Corp. | |
#350 – 3605 Gilmore Way Burnaby, B.C. V5G 4X5 Canada Email: | |
abhijit.ahir@clarius.me Tel: (+1) 778-800-9975 | |
Fax: (+1) 778-800-9974 | |
Contact Person: | Emergo Global Representative, LLC |
816 Congress Avenue, Suite 1400 | |
Austin, TX 78701 USA Tel: (+1) 512-327-9997 | |
Date Prepared: | September 5, 2017 |
-
- Name of the device, including the trade or proprietary name, if applicable, the common or usual name, and the classification, if known:
Device Name: | Clarius Ultrasound Scanner |
---|---|
Common Name: | Diagnostic Ultrasound System and Accessories |
Classification: | Class II |
Classification Names: |
21 CFR Section | Classification Name | Product Code |
---|---|---|
892.1550 | Ultrasonic Pulsed Doppler Imaging System | 90 IYN |
892.1560 | Ultrasonic Pulsed Echo Imaging System | 90 IYO |
892.1570 | Diagnostic Ultrasound Transducer | 90 ITX |
3. Substantially Equivalent Devices:
Device Name | 510(k) Number |
---|---|
FUJIFILM SonoSite Edge Ultrasound System | K133454 |
Clarius Ultrasound System | K163138 |
Device Description
The Clarius Ultrasound System is a portable, general-purpose, software-controlled, diagnostic ultrasound system used to acquire and display high-resolution, real-time ultrasound data through a commercial off the-shelf (COTS) iOS or Android device. The Clarius Ultrasound System comprises a series of wireless transducers employing Bluetooth and Wi-Fi-based technology to communicate with traditional tablet/smartphone devices via direct Wi-Fi. This allows the user to export ultrasound images and display them across a range of portable personal devices.
10
Image /page/10/Picture/0 description: The image shows the logo for Clarius. The logo consists of an orange symbol that looks like three curved lines forming a C shape, followed by the word "clarius" in dark blue. The word "clarius" is written in lowercase letters.
Image /page/10/Figure/1 description: The image shows a diagram of an ultrasound system. On the left side of the image, there is a device that contains the battery, Wi-Fi, power circuitry, ultrasound system-on-chip beamforming and processing, transmit/receive analog interface, and transducer stack. The device is scanning a patient. On the right side of the image, there is a Wi-Fi-enabled smartphone or tablet that displays the ultrasound image and user interface.
Ultrasound Probe
User Interface / Display
Piezoelectric material in the systems transmits high frequency, non-ionizing sound waves to the designated region of the body and converts the subsequent echoes detected to electronic signals in order to construct an image of the internal structures of an anatomical field. This image is sent wirelessly to an external (COTS) iOS or Android viewing device on which the image can be displayed. The transducer houses a battery and power generator, multichannel beam former, pre-scan converter, and Wi-Fi components. The battery is removable and comes with a separate charger. Communication between the transducer and the compatible viewing device will be via Wi-Fi Direct® (Ad-Hoc mode with security) for easy pairing.
The Clarius Ultrasound System product/package components include:
-
- Software:
- The Ultrasound App (Clarius App) for iOS; OR
- The Ultrasound App (Clarius App) for Android. ●
-
- Transducers/Scanners:
- Clarius C3 Scanner (C3 Convex Transducer);
- Clarius C3 Scanner (C3 Convex Transducer) with Clarius C3-L Clip-on; ●
- Clarius C7 Scanner (C7 Convex Transducer); OR
- . Clarius L7 Scanner (L7 Linear Transducer).
11
Image /page/11/Picture/0 description: The image shows the Clarius logo. The logo consists of an orange icon on the left and the word "clarius" in dark blue on the right. The icon is made up of three curved lines that resemble the letter "C". The word "clarius" is written in a sans-serif font.
3. Accessories:
- a. Clarius-Built:
- о Battery Pack (Li-ion); and
- Battery Charger. O
- b. OEM/Off-The-Shelf Product(s):
- O Medical Power Supply (Off-the-shelf power adaptor from SL Power Electronics, USA; Model Number ME20A1203B02; Approved in the US); and
- Aquasonic 100 Ultrasound Transmission Gel (Off-the-shelf ultrasound gel from Parker o Laboratories Inc., USA; Approved in the US).
The concept of the Clarius Ultrasound System transducers and software is primarily to provide an easy to use, high-performance, low-cost, ultrasound platform for teaching and clinical applications. The Clarius Ultrasound System is intended for use in professional healthcare facilities where healthcare is provided by trained medical professionals. The device is also intended for use in Emergency Medical Service, ambulance, or rotary aircraft environments.
Changes Implemented
The Clarius Ultrasound System obtained market clearance on November 30, 2016, under 510(k) submission number K163138. Two devices were listed on the previous submission – the Clarius C3 Scanner (C3 Convex Transducer) and the Clarius L7 Scanner (L7 Linear Transducer) – which were approved for B-mode only.
This submission includes the addition of M-mode, color doppler, and combined modes (i.e., B+M; B+CD; B+PD) for these two devices. A new device has been added – the Clarius C7 Scanner (C7 Convex Transducer). This device will also operate using B-mode, M-mode, color doppler, power doppler, and combined modes. All three devices include the addition of intraoperative (abdominal organs & vascular) as a clinical application.
The Clarius C3 Scanner includes the addition of Cardiac Pediatric in B-mode, M-mode, Color Doppler, and combined modes (i.e., B+M and B+CD). The Clarius L7 Scanner includes ophthalmic as an additional application available in B-mode only.
Clarius is also introducing a new accessory for the C3 Scanner; a linear adapter, which will be referred to as the Clarius C3-L Clip-on. This optional accessory provides enhanced versatility of the Clarius C3 Scanner to allow the device to be used a linear transducer.
All devices are compliant with IEC 60601-1-12 Edition 1.0 2014-06 (Recognition Number 19-15). This collateral standard defines the requirements for medical electrical equipment and systems intended for use in the emergency medical services environment. As such, the disclaimer that these devices cannot be used in emergency medical environments is no longer applicable. All devices are also IP67 rated, certifying that the device can be immersed in water of a depth of up to 1 meter for 30 minutes and is dust tight.
Intended Use
The Clarius Ultrasound Scanner is a software-based ultrasound imaging system and accessories, intended for diagnostic imaging in B-mode, M-mode, Color Doppler, and Combined (B+M; B+Color Doppler; and B+Power Doppler). It is indicated for diagnostic ultrasound imaging and fluid flow analysis in the following applications: ophthalmic, fetal, abdominal, intra-operative (nonneurological), pediatric, small organ, cephalic (adult), musculo-skeletal (conventional, superficial),
12
Image /page/12/Picture/0 description: The image shows the Clarius logo. The logo consists of an orange symbol that looks like three curved lines forming a stylized "C". To the right of the symbol is the word "clarius" in a dark blue, sans-serif font. The logo is clean and modern in appearance.
urology, gynecology, cardiac (adult, pediatric), fetal echo, peripheral vessel, carotid, and procedural guidance of needles into the body.
The system is a transportable ultrasound system intended for use in environments where is provided by trained healthcare professionals.
Contraindications
Do not use the Clarius Ultrasound Scanner in the following situations. Doing so may produce images with inaccurate results:
- Patients who have had surgery, which may have changed the composition of the examining tissue (for example, a mastectomy), as this could skew or alter the measured density.
- . Patients whose bodies contain foreign artifacts (for example, implants), in the examining tissue.
- . Endocavitary use; (i.e., defined as introducing a scanner within a (body) cavity or organ. E.g. an atrium, esophagus, rectum or vagina).
For Use in Surgical Environments
Before use of the Clarius Scanner for intra-operative procedures, follow instructions for high-level disinfection, then cover the Clarius Scanner with a sheath:
- Use only CIVCO REF 610-1212.
- Download the usage instructions from http://civco.com/mmi/ultrasound/covers/generalpurpose/Latex-Free-Wireless-Ultrasound-Probe-Covers-610-1212.htm and read all the information before use.
When finished, immediately clean the scanner, followed by another high-level disinfection.
If the sheath breaks during the intra-operative procedure, dispose the sheath and follow the same cleaning and high-level disinfecting process as above, then cover the Clarius Ultrasound Scanner with a new sheath before continuing to use it.
Predicate Devices
Equivalent devices are referred to as predicate devices in alignment with the FDA's standard terminology for comparable devices. The predicate devices selected to demonstrate equivalence are:
| 1. Device Name
Clarius Ultrasound System | FDA 510(k) Number
(K163138) |
|---------------------------------------------------|--------------------------------|
| 2. Device Name
SonoSite Edge Ultrasound System | FDA 510(k) Number
(K133454) |
Determination of Substantial Equivalence
The Clarius Ultrasound system is a Track 3 system that employs the same fundamental scientific technology as that cleared with K133454 and K163138. All indications for use introduced by the Clarius Ultrasound Scanner are similar to at least one of the predicate devices. A comparison table is provided below:
13
Image /page/13/Picture/0 description: The image shows the logo for Clarius. The logo consists of an orange symbol on the left and the word "clarius" in dark blue on the right. The symbol is made up of three curved lines that resemble sound waves or a stylized letter C.
| Criteria for Comparison | Clarius Ultrasound Scanner | Clarius Ultrasound System
(K163138) | FUJIFILM SonoSite Edge
Ultrasound System
(K133454) |
|-------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Portability | Portable ultrasound system | Portable ultrasound system | Portable ultrasound system |
| Power Source | Removable battery (Li-ion) | Removable battery (Li-ion) | Battery or AC power |
| Display | iOS or Android mobile device | iOS or Android mobile device | Inbuilt digital display |
| Wireless Capability | Communicates wirelessly via Wi-Fi and Bluetooth | Communicates wirelessly via Wi-Fi and Bluetooth | Communicates via cable |
| 510(k) Track | Track 3 | Track 3 | Track 3 |
| Transducer Types | - Convex Array
- Linear Array
- Phased Array | - Convex Array
- Linear Array | - Convex Array
- Linear Array
- Phased Array
- Intracavity
- Trans-esophageal |
| Intended Use | Diagnostic ultrasound imaging and fluid flow analysis | Diagnostic ultrasound imaging and fluid flow analysis | Diagnostic ultrasound imaging and fluid flow analysis |
| Indications of Use | - Ophthalmic - Fetal
- Abdominal
- Intraoperative (Ab/Vasc)
- Pediatric
- Small organ
- Adult Cephalic
- Musculo-skel. (Conv.)
- Musculo-skel. (Superfic.)
- Urology
- Gynecology
- Cardiac Adult
- Cardiac Pediatric
- Fetal Echo
- Peripheral vessel
- Carotid
- Needle guidance | - Fetal
- Abdominal
- Pediatric
- Small organ
- Musculo-skel. (Conv.)
- Musculo-skel. (Superfic.)
- Urology
- Gynecology
- Cardiac Adult
- Cardiac Pediatric
- Fetal Echo
- Peripheral vessel
- Carotid
- Needle guidance | - Ophthalmic
- Fetal
- Abdominal
- Intraoperative (Ab/Vasc)
- Intraoperative (Neuro)
- Pediatric
- Small organ
- Neonatal cephalic
- Adult Cephalic
- Trans-Rectal
- Trans-Vaginal
- Musculo-skel. (Conv.)
- Musculo-skel. (Superfic.)
- Gynecology
- Cardiac Adult
- Cardiac Pediatric
- Trans-esophageal (Card.)
- Peripheral vessel
- Needle guidance |
| Modes of Operation | - B-mode - M-mode
- Color Doppler
- Power Doppler
- Combined (B+M, B+CD, B+PD) | - B-Mode | - B-Mode
- M-Mode
- Color Doppler
- Color M Doppler
- Power Doppler
- PWD
- CWD
- Harmonic Imaging
- Combined (B+M, B+PWD,
B+CD, B+Power, B+CWD) |
Equivalency Conclusion
The subject device does not introduce any new technology or indications for use; therefore, the system is substantially equivalent to the predicate devices.
14
Image /page/14/Picture/0 description: The image shows the logo for Clarius. The logo consists of an orange symbol on the left and the word "clarius" in dark blue on the right. The symbol is made up of three curved lines that resemble a "C" shape.
Nonclinical Performance Data
Nonclinical performance tests show compliance to the following standards:
Reference No. | Year | Title |
---|---|---|
AAMI/ANSI | ||
ES60601-1 | 2012 | Medical Electrical Equipment - Part 1: General Requirements for Basic Safety and Essential Performance |
IEC 60601-1-2 | 2007 | |
& | ||
2014 | Medical electrical equipment – Part 1-2: General requirements for basic safety and essential performance - Collateral Standard: Electromagnetic Capability - Requirements and tests. (4th Edition) | |
IEC 60601-1-6 | 2013 | Medical electrical equipment - Part 1-6: General requirements for basic safety and essential performance -Collateral standard: Usability |
IEC 60601-1-12 | 2014 | Medical Electrical Equipment - Part 1-12: General requirements for basic safety and essential performance - Collateral Standard: Requirements for medical electrical equipment and medical electrical systems used in the emergency medical services environment |
IEC 60601-2-37 | 2004 | Medical electrical equipment – Part 2-37: Particular requirements for the basic safety and essential performance of ultrasonic medical diagnostic and monitoring equipment. (3rd and 4th Edition) |
IEC 62133 | 2012 | Secondary Cells and Batteries Containing Alkaline or Other Non-Acid Electrolytes - Safety Requirements for Portable Sealed Secondary Cells, And for Batteries Made from Them, For Use in Portable Applications [Including: Corrigendum 1 (2013)] |
IEC 62366 | 2014 | Consolidated Version Medical Devices - Application of Usability Engineering to Medical Devices |
ISO 10993-1 | 2009 | Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process |
ISO 10993-5 | 2014 | Biological Evaluation of Medical Devices - Part 5: Tests for In Vitro Cytotoxicity |
ISO 10993-10 | 2014 | Biological Evaluation of Medical Devices - Part 10: Tests for Irritation and Skin Sensitization |
ISO-10993-12 | 2014 | Biological Evaluation of Medical Devices - Part 12: Sample Preparation and Reference Materials |
ISO 62304 | 2006 | Medical Device Software - Software Life Cycle Processes |
ISO 15223-1 | 2012 | Medical Devices - Symbols to be Used with Medical Devices Labels, Labeling, and Information to be Supplied - Part 1: General Requirements |
ISO 14971 | 2007 | Medical Devices - Applications of Risk Management to Medical Devices |
NEMA UD 2 | 2009 | Acoustic Output Measurement Standard for Diagnostic Ultrasound Equipment - Revision 3 |
Clinical Testing
The Clarius Ultrasound Scanner did not require clinical testing to establish substantial equivalence.
Quality Assurance Measures
Quality assurance measures applied to the system design and development include, but were not limited to: risk analysis, verification and validation, product specifications, and design reviews.
Conclusion
This device is a modification of an existing licensed device using technologies that exist on the market today. The development and testing conducted on the device ascertain that it is safe for use by physicians. The Clarius Ultrasound Scanner does not introduce indications for use, technological features, or system characteristics that are not seen in its predicate device is substantially equivalent in safety and effectiveness to these predicate devices.